Trial Profile
Open Label, Nonrandomized Clinical Trial of Safety and Tolerability of Enfuviritide (Fuzeon, HIV Fusion Inhibitor) in Patients With Advanced HIV1 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Roche
- 02 Jun 2006 New trial record.